CA2275377A1 - Encapsulation - Google Patents
Encapsulation Download PDFInfo
- Publication number
- CA2275377A1 CA2275377A1 CA002275377A CA2275377A CA2275377A1 CA 2275377 A1 CA2275377 A1 CA 2275377A1 CA 002275377 A CA002275377 A CA 002275377A CA 2275377 A CA2275377 A CA 2275377A CA 2275377 A1 CA2275377 A1 CA 2275377A1
- Authority
- CA
- Canada
- Prior art keywords
- microcapsule
- encapsulent
- acid
- mixture
- resin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J13/00—Colloid chemistry, e.g. the production of colloidal materials or their solutions, not otherwise provided for; Making microcapsules or microballoons
- B01J13/02—Making microcapsules or microballoons
- B01J13/025—Applications of microcapsules not provided for in other subclasses
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Dispersion Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Manufacturing Of Micro-Capsules (AREA)
- Processes Of Treating Macromolecular Substances (AREA)
- Compositions Of Macromolecular Compounds (AREA)
Abstract
A colloidal aggregate suitable for use in the curing of resins comprises a continuous phase of a water based encapsulent material and a dispersed phase comprising one or more strong acids. The continuous phase advantageously comprises a mixture of gelatin and xanthan gum. The aggregate is sonicated to encapsulate the acid in the encapsulent material. The encapsulated acid is mixed with a curable resin. The acid capsules may be ruptured by any suitable means, but particularly ultrasound, to release the acid to initiate curing of the resin.
Description
~NCAP~,ILATION
The present invention relates to microcapsules of acid and to a method of their production. The invention is particularly, but not exclusively concerned with microcapsules of catalysts and/or initiators used in the curing of synthetic resins.
In the majority of uses, the processing and curing of resins is carried out under controlled conditions. However, circumstances occur when it is necessary to control/prevent the curing of a resin before an appropriate time in order to attain the best utilisation of the resin.
The majority of thermoset resin applications use heat to cure the resin, the application of heat causing a catalyst and7or p~oimoter in the resin to accelerate the cross-linking of resin molecules.
1 ~ However; even if heat is not applied, the resin will cure over a period of days, thereby restricting the time during which uncured resin can be stored. Therefore, from the above it can be seen that as soon as the resin is mixed with its catalyst and is used for the specific application there is a race against time to get the resin/catalyst system in place.
The industry is aware of this problem and some attempts have AMENDED SHEET
The present invention relates to microcapsules of acid and to a method of their production. The invention is particularly, but not exclusively concerned with microcapsules of catalysts and/or initiators used in the curing of synthetic resins.
In the majority of uses, the processing and curing of resins is carried out under controlled conditions. However, circumstances occur when it is necessary to control/prevent the curing of a resin before an appropriate time in order to attain the best utilisation of the resin.
The majority of thermoset resin applications use heat to cure the resin, the application of heat causing a catalyst and7or p~oimoter in the resin to accelerate the cross-linking of resin molecules.
1 ~ However; even if heat is not applied, the resin will cure over a period of days, thereby restricting the time during which uncured resin can be stored. Therefore, from the above it can be seen that as soon as the resin is mixed with its catalyst and is used for the specific application there is a race against time to get the resin/catalyst system in place.
The industry is aware of this problem and some attempts have AMENDED SHEET
-2 been made to solve 'rt by developing special resins which are curable by light radiation.
Ultra small microcapsules of the order of less than 100 micron diameter, are formed which are of appropriate size to be used in thermoset applications when such microcapsules are dispersed throughout the resin. When the microcapsules are so small they can be uniformly dispersed and will not settle out in the resin.
One particular class of resin is that of phenolic resins which are the products of reactions between phenols (commonly phenol) and aldehydes (typically formaldehyde). One of the main advantages of using phenolic resin systems for the thermoset resin industry is that the resin initially comprises a low molecular weight fusible solid resin that may be easily handled and subsequently, upon curing, forms a high molecular weight, strong, heat resistant material.
Phenolic resins are usually initiated/catalysed by the addition of strong acids such as sulphuric acid, hydrochloric acid, phosphoric acid, Toluenesulphonic acid and the like, all of which are extremely corrosive and difficult to handle. The corrosive nature of the acids is one of the main factors which have made them exceptionally difficult to encapsulate and without some form of encapsulation or controlled release it is impossible to control the release of the acid into the
Ultra small microcapsules of the order of less than 100 micron diameter, are formed which are of appropriate size to be used in thermoset applications when such microcapsules are dispersed throughout the resin. When the microcapsules are so small they can be uniformly dispersed and will not settle out in the resin.
One particular class of resin is that of phenolic resins which are the products of reactions between phenols (commonly phenol) and aldehydes (typically formaldehyde). One of the main advantages of using phenolic resin systems for the thermoset resin industry is that the resin initially comprises a low molecular weight fusible solid resin that may be easily handled and subsequently, upon curing, forms a high molecular weight, strong, heat resistant material.
Phenolic resins are usually initiated/catalysed by the addition of strong acids such as sulphuric acid, hydrochloric acid, phosphoric acid, Toluenesulphonic acid and the like, all of which are extremely corrosive and difficult to handle. The corrosive nature of the acids is one of the main factors which have made them exceptionally difficult to encapsulate and without some form of encapsulation or controlled release it is impossible to control the release of the acid into the
-3-resin. Another class of resins is urea formaldehyde is also of interest.
An object of this invention is to provide capsules of strong acids which are readily dispersable in resin material without acid leakage.
Furthermore, the present invention also seeks to provide curable resin systems for the production of rigid articles wherein the resin can be cured readily and quickly, but retains a long shelf life making it particularly suitable for use in the thermoset resin industry.
According to one aspect of the present invention there is provided a microcapsule suitable for use in the curing of resins comprising a membrane of a water based encapsulation material and an encapsulated phase comprising one or more strong acids wherein the membrane may be ruptured by an external energy source to release the acid.
Preferably the encapsulent comprises a water based acid resistant gelatin.
The strong acid may comprise sulphuric acid, hydrochloric acid, phosphoric acid and toluene sulphonic acid or a mixture thereof.
According to another aspect of the invention there is provided a resin system for the production of rigid articles wherein said resin .
systems comprises resin and a dispersed catalyst/initiator said catalystlinitiator being microcapsute comprising a membrane of a water based encapsulent material and a dispersed phase comprising one or more strong acids wherein the membrane may be ruptured by an external energy source to release the acid into the resin and thereby initiatinglcatalysing the resin curing.
One advantage of this type of encapsulation over the prior art is the fact that previously the encapsulated reactant was produced in the form of dry capsules which were often poorly dispersed when mixed in with resin, whereas the materials of the present invention are readily dispersed ensuring intimate dispersion in the resin and significantly reducing the likelihood of the presence of large conglomerates of capsules.
The invention has a general application in that a resin impregnated absorbent material with the dispersed colloidal capsules therein can be shaped to a final form and the colloidal capsules ruptured, for example by heating or electromagnetic energy, to release the catalyst or promotes, to cause curing of the resin and absorbent material in said final form.
In one embodiment of the present invention the encapsulated ZO catalyst is admixed with the curable resinous material which is then used to impregnate a fibrous carrier layer.
The fibrous layer can be shaped to any desired shape, such as a boat or moulded part for a vehicle whilst the resin is uncured, and then the resin can be cured for example by the application heat or electromagnetic energy to rupture the colloidal capsules.
The resinlcolloidal capsule carrier material preferably has a fibrous sheet structure including a mat, a web or randomly orientated fibres and the fibres may be of glass and/or of natural and synthetic origin.
According to a still further aspect of the present invention there is also provided a method for the microencapsulation of one or more strong acids suitable for use as catalysts, prorr~oters or initiators in resin curing reactions, comprising the following steps:-mixing the acid(s), a water based encapsulent and water, sonicating the mixture so formed to encapsulate the acids) in IS the encapsulent, and substantially removing surplus water from the mixture to form a microcapsule of the acid in the encapsulent.
By way of a specific example when acid resistant gelatin is used application of ultrasonic energy or gelatin in the sonicating step causes free-radical induced cross-linking of protein molecules. Highly reactive radicals in particular H~ and OH~ are ultrasonically produced from water and react with molecular oxygen present in the solution/air to form a superoxide HOZ,). Superoxide reacts with protein molecules to produce disulphuric bonding usually between cysteine residues. Ultrasound can produce a high concentration of proteinaceous colloidal capsules with narrow size distributions, generally in region of 9-20 microns.
A typical ultrasonic reactor apparatus for use in the preparations of this invention comprises a collimated 20 Khz beam from a lead zirctinate ~ titanate transducer and the reaction may be carried out in a glass sonication cell in an inert atmosphere, preferably in an atmosphere of argon. An amplifying horn; preferably made of titanium may be fixed adjacent to .the transducer, for.
amplification of the signal thereof_ Because of temperature rises due to 'the reaction processes 'the sonication cell is preferably retained in a water bath. Audible sound may also be used.
Preferably in the water removal step, the aqueous mixture of the capsules formed in the sonification step are heated .for. a period of about 24 hours at a temperature below the rupture temperature of around 80°C and is preferably heated between 60 and 70°C.
The present invention will be better understood by way of the following examples which describe the encapsulation of strong acids in water based encapsulents for use as catalystslinitiators for polymerisation reactions.
Example 1 The curing of phenolic resin is generally initiatedlcatalysed by the addition of strong acids and the reaction proceeds at ambient temperature.
In this example the curing agent which was encapsulated was a propriety blend of phosphoric and toluene sulphonic acids.
One part by weight of the acid mixture was mixed with 3 parts w by weight of food grade gelatin (200 Bloom) dispersed in 3 parts of water.
This mixture was sonicated for a period of three minutes (power 100V11) using a 20 Khz probe: The high intensity ultrasound, ~, produced intermediate proteinaceous capsules in a substantially-i 5 aqueous 'medium and were of a sizes' less than 100 advantageously microns wherein capsules are dispersed in water and comprise an outer layer of gelatin encapsulating a strong acid core.
It was found however that because acid mixture contained strong acids, a gel/water boundary developed around the acid catalyst leading to diffusion of the acid through the shell. !t would seem that is because the water present in and around each capsule _$_ shell acts as a carrier for the acid.
tt was subsequently found that an improved encapsulated product was prepared by eliminating water from the aqueous mixture to prevent the acids traversing the cell wall. The sonicated mixture was therefore heated in an oven at 70'C until the three parts water had been removed to form the end product material.
Example 2 In a further experiment 10% by weight of acid mixture was mixed with 10% of acid resistant gelatin (Gelatex, Che~n. Colloids Ltd) and 10% water and the mixture was sonicated for 3 minutes using 20KHz probe (70 Watts) producing proteinaceous colloidal capsules with particle sizes of less than 100 microns advantageously between 1 and 20 microns.
The gelatin/water/acid colloid was heated in an oven at 60'C
for 24 hours to remove the water from the gelatin/water boundary leaving a gelatin capsule.
It has been found that gelatin capsules of the present invention of acid mixture have a shelf life of at least 3 months and that upon heating samples thereof up to 90'C in the presence of phenolic resins a cure is obtained within 5 minutes.
The encapsulation material may take many different forms.
For example, a material comprising a combination of gelatin with xanthan gum has been found to be particularly advantageous combining longtime resistance to acid attack with ready encapsulation of acid and rupturing of the encapsulation on application of an external energy source such as ultrasound.
Preferred formulations of the above ingredients lie in the following range:-Xanthan Gum 0.1 - 50.1 Gelatin 99.9 - 49.9 The material is produced by the adhesion, agglomeration and enrobing of gelatin with xanthan gum. Apart from the above ingredient combinations, the following ingredients in the following ingredient combinations may also be used:-(a) Gelatin 99.9 - 49.9 Gellan Gum 0.1 - 50.1 (b) Gum Arabic 99.9 - 49.9 Xanthan Gum 0.1 - 50.1 (c) Gum Arabic 99.9 - 49.9 Gellan Gum 0.1 - 50.1 (d/ Gellatin 99.9 - 49.9 Tragacanth 0.1 - 50.1 (e) Gum Arabic 99.9 - 49.9 Tragacanth 0.1 - 50.1 (f) Gelatin 99.9 - 49.9 Gum Arabic 0.1 - 50.1 (g) Gelatin 99.9 - 49.9 Polyglycol Alginates 0.1 - 50.1 A blend of all the above combinations may also be employed.
In any combination comprising gelatin any of the following may be employed as alternatives:
- Hydrolysed Gelatin - Alginates Carrageenan (Kappa, Iota and Lambda) - Locust Bean Gum - Gum Arabic - High Methoxyl Pectins - Gellan Gum - Methyl Cellulose and Methyl Hydroxpropyl Cellulose or any mixture/modifications of the above - Agar In any combination comprising xanthan gum any of the foNowing may be employed as alternatives:-- Hydroxyethyl Cellulose ' - Carboxymethyl Cellulose - Gum Arabic - Tragacanth - Gelian Gum - Sulphuric Acid Monoesters of Gum Tragacanth - Polyglycol Alginates - Low Methoxyl Pectins In the above, the following terms have the following meanings:-(a) Gelatin and Hl~rdrolysed Gelatin Protein derived from the hydrolysis of animal collagen i0 (including ash) or any short chain combination of constituent amino acids.
(b) Carrageenan and Agar Products extracted from red seaweed having galatose backbone joined together by alternating glycosidic 15 linkages.
(c) Guar. Locust Bean Tara Cassia Mesauite and Fenugreek gum Galactomannans - a family of linear polysaccharides based on a backbone of ~i(1-4)-linked D-mannose 20 residues.
(d) Gum Arabic Gum Tragiacanth and Gum Ka~yra Exudate Gums - yielded from species of trees and shrubs, which first appears as a liquid and is dried in the sun and air to form a hard glassy lump.
(e) Xanthan and Gellan Gum Biosynthetic Polysaccharide Gums - produced by fermentation using specific bacteria.
(f) Alginates and Alginate Esters Salts of Alginic Acid - with a degree of polymerisation usually in the range of 700 - 3000 corresponding to molecular weights of approximately 20,000 - 600,000.
Propylene Glycol Alginate (PGA) is an ester of alginic acid and propylene glycol.
(g) Methyrl Cellulose. Methyl Hydroxl~ro~yl Cellulose Hvdroxvethyrl Cellulos and Carboxyrmet yl Cellulose Cellulose Ethers - prepared by reacting cellulose with caustic to form 'alkali cellulose' which in turn is alkylated or alkoxylated in the presence or absence of inert diiuent or by Williamson Etherification reaction.
(h) Low Methoxyrl Pectins and High Methoxyl Pectins Pectins - are the partial breakdown products of complex structures in plant cell wall (normally fruits). These can .
be modified by de-esterification to produce high methoxyl and low methoxy! pectins.
The capsules of acid may be mixed with the resin to be cured by any suitable means. The resins may be phenolic or urea formaldehyde. The very small size of the capsules facilitates dispersal in the resin. The mixing process is low energy, low shear to avoid premature rupturing of the capsules. A suitable form of mixer may be a paddle mixer. The shelf life of a product comprising resin to be cured and encapsulated acid may be tailored to a customer's requirements_ Shelf lives of at least three months and possibly of longer than one year may be achieved. -The capsules dispersed in the resin may be ruptured ~to release the acid to initiate curing by any suitable means: Appropriate means 1:. include heating, sound, ultrasound; radio waves, microwaves or pressure_ The latter may be particularly advantageous in the production of products which inherently involve the application of pressure such as for example laminated products.
An object of this invention is to provide capsules of strong acids which are readily dispersable in resin material without acid leakage.
Furthermore, the present invention also seeks to provide curable resin systems for the production of rigid articles wherein the resin can be cured readily and quickly, but retains a long shelf life making it particularly suitable for use in the thermoset resin industry.
According to one aspect of the present invention there is provided a microcapsule suitable for use in the curing of resins comprising a membrane of a water based encapsulation material and an encapsulated phase comprising one or more strong acids wherein the membrane may be ruptured by an external energy source to release the acid.
Preferably the encapsulent comprises a water based acid resistant gelatin.
The strong acid may comprise sulphuric acid, hydrochloric acid, phosphoric acid and toluene sulphonic acid or a mixture thereof.
According to another aspect of the invention there is provided a resin system for the production of rigid articles wherein said resin .
systems comprises resin and a dispersed catalyst/initiator said catalystlinitiator being microcapsute comprising a membrane of a water based encapsulent material and a dispersed phase comprising one or more strong acids wherein the membrane may be ruptured by an external energy source to release the acid into the resin and thereby initiatinglcatalysing the resin curing.
One advantage of this type of encapsulation over the prior art is the fact that previously the encapsulated reactant was produced in the form of dry capsules which were often poorly dispersed when mixed in with resin, whereas the materials of the present invention are readily dispersed ensuring intimate dispersion in the resin and significantly reducing the likelihood of the presence of large conglomerates of capsules.
The invention has a general application in that a resin impregnated absorbent material with the dispersed colloidal capsules therein can be shaped to a final form and the colloidal capsules ruptured, for example by heating or electromagnetic energy, to release the catalyst or promotes, to cause curing of the resin and absorbent material in said final form.
In one embodiment of the present invention the encapsulated ZO catalyst is admixed with the curable resinous material which is then used to impregnate a fibrous carrier layer.
The fibrous layer can be shaped to any desired shape, such as a boat or moulded part for a vehicle whilst the resin is uncured, and then the resin can be cured for example by the application heat or electromagnetic energy to rupture the colloidal capsules.
The resinlcolloidal capsule carrier material preferably has a fibrous sheet structure including a mat, a web or randomly orientated fibres and the fibres may be of glass and/or of natural and synthetic origin.
According to a still further aspect of the present invention there is also provided a method for the microencapsulation of one or more strong acids suitable for use as catalysts, prorr~oters or initiators in resin curing reactions, comprising the following steps:-mixing the acid(s), a water based encapsulent and water, sonicating the mixture so formed to encapsulate the acids) in IS the encapsulent, and substantially removing surplus water from the mixture to form a microcapsule of the acid in the encapsulent.
By way of a specific example when acid resistant gelatin is used application of ultrasonic energy or gelatin in the sonicating step causes free-radical induced cross-linking of protein molecules. Highly reactive radicals in particular H~ and OH~ are ultrasonically produced from water and react with molecular oxygen present in the solution/air to form a superoxide HOZ,). Superoxide reacts with protein molecules to produce disulphuric bonding usually between cysteine residues. Ultrasound can produce a high concentration of proteinaceous colloidal capsules with narrow size distributions, generally in region of 9-20 microns.
A typical ultrasonic reactor apparatus for use in the preparations of this invention comprises a collimated 20 Khz beam from a lead zirctinate ~ titanate transducer and the reaction may be carried out in a glass sonication cell in an inert atmosphere, preferably in an atmosphere of argon. An amplifying horn; preferably made of titanium may be fixed adjacent to .the transducer, for.
amplification of the signal thereof_ Because of temperature rises due to 'the reaction processes 'the sonication cell is preferably retained in a water bath. Audible sound may also be used.
Preferably in the water removal step, the aqueous mixture of the capsules formed in the sonification step are heated .for. a period of about 24 hours at a temperature below the rupture temperature of around 80°C and is preferably heated between 60 and 70°C.
The present invention will be better understood by way of the following examples which describe the encapsulation of strong acids in water based encapsulents for use as catalystslinitiators for polymerisation reactions.
Example 1 The curing of phenolic resin is generally initiatedlcatalysed by the addition of strong acids and the reaction proceeds at ambient temperature.
In this example the curing agent which was encapsulated was a propriety blend of phosphoric and toluene sulphonic acids.
One part by weight of the acid mixture was mixed with 3 parts w by weight of food grade gelatin (200 Bloom) dispersed in 3 parts of water.
This mixture was sonicated for a period of three minutes (power 100V11) using a 20 Khz probe: The high intensity ultrasound, ~, produced intermediate proteinaceous capsules in a substantially-i 5 aqueous 'medium and were of a sizes' less than 100 advantageously microns wherein capsules are dispersed in water and comprise an outer layer of gelatin encapsulating a strong acid core.
It was found however that because acid mixture contained strong acids, a gel/water boundary developed around the acid catalyst leading to diffusion of the acid through the shell. !t would seem that is because the water present in and around each capsule _$_ shell acts as a carrier for the acid.
tt was subsequently found that an improved encapsulated product was prepared by eliminating water from the aqueous mixture to prevent the acids traversing the cell wall. The sonicated mixture was therefore heated in an oven at 70'C until the three parts water had been removed to form the end product material.
Example 2 In a further experiment 10% by weight of acid mixture was mixed with 10% of acid resistant gelatin (Gelatex, Che~n. Colloids Ltd) and 10% water and the mixture was sonicated for 3 minutes using 20KHz probe (70 Watts) producing proteinaceous colloidal capsules with particle sizes of less than 100 microns advantageously between 1 and 20 microns.
The gelatin/water/acid colloid was heated in an oven at 60'C
for 24 hours to remove the water from the gelatin/water boundary leaving a gelatin capsule.
It has been found that gelatin capsules of the present invention of acid mixture have a shelf life of at least 3 months and that upon heating samples thereof up to 90'C in the presence of phenolic resins a cure is obtained within 5 minutes.
The encapsulation material may take many different forms.
For example, a material comprising a combination of gelatin with xanthan gum has been found to be particularly advantageous combining longtime resistance to acid attack with ready encapsulation of acid and rupturing of the encapsulation on application of an external energy source such as ultrasound.
Preferred formulations of the above ingredients lie in the following range:-Xanthan Gum 0.1 - 50.1 Gelatin 99.9 - 49.9 The material is produced by the adhesion, agglomeration and enrobing of gelatin with xanthan gum. Apart from the above ingredient combinations, the following ingredients in the following ingredient combinations may also be used:-(a) Gelatin 99.9 - 49.9 Gellan Gum 0.1 - 50.1 (b) Gum Arabic 99.9 - 49.9 Xanthan Gum 0.1 - 50.1 (c) Gum Arabic 99.9 - 49.9 Gellan Gum 0.1 - 50.1 (d/ Gellatin 99.9 - 49.9 Tragacanth 0.1 - 50.1 (e) Gum Arabic 99.9 - 49.9 Tragacanth 0.1 - 50.1 (f) Gelatin 99.9 - 49.9 Gum Arabic 0.1 - 50.1 (g) Gelatin 99.9 - 49.9 Polyglycol Alginates 0.1 - 50.1 A blend of all the above combinations may also be employed.
In any combination comprising gelatin any of the following may be employed as alternatives:
- Hydrolysed Gelatin - Alginates Carrageenan (Kappa, Iota and Lambda) - Locust Bean Gum - Gum Arabic - High Methoxyl Pectins - Gellan Gum - Methyl Cellulose and Methyl Hydroxpropyl Cellulose or any mixture/modifications of the above - Agar In any combination comprising xanthan gum any of the foNowing may be employed as alternatives:-- Hydroxyethyl Cellulose ' - Carboxymethyl Cellulose - Gum Arabic - Tragacanth - Gelian Gum - Sulphuric Acid Monoesters of Gum Tragacanth - Polyglycol Alginates - Low Methoxyl Pectins In the above, the following terms have the following meanings:-(a) Gelatin and Hl~rdrolysed Gelatin Protein derived from the hydrolysis of animal collagen i0 (including ash) or any short chain combination of constituent amino acids.
(b) Carrageenan and Agar Products extracted from red seaweed having galatose backbone joined together by alternating glycosidic 15 linkages.
(c) Guar. Locust Bean Tara Cassia Mesauite and Fenugreek gum Galactomannans - a family of linear polysaccharides based on a backbone of ~i(1-4)-linked D-mannose 20 residues.
(d) Gum Arabic Gum Tragiacanth and Gum Ka~yra Exudate Gums - yielded from species of trees and shrubs, which first appears as a liquid and is dried in the sun and air to form a hard glassy lump.
(e) Xanthan and Gellan Gum Biosynthetic Polysaccharide Gums - produced by fermentation using specific bacteria.
(f) Alginates and Alginate Esters Salts of Alginic Acid - with a degree of polymerisation usually in the range of 700 - 3000 corresponding to molecular weights of approximately 20,000 - 600,000.
Propylene Glycol Alginate (PGA) is an ester of alginic acid and propylene glycol.
(g) Methyrl Cellulose. Methyl Hydroxl~ro~yl Cellulose Hvdroxvethyrl Cellulos and Carboxyrmet yl Cellulose Cellulose Ethers - prepared by reacting cellulose with caustic to form 'alkali cellulose' which in turn is alkylated or alkoxylated in the presence or absence of inert diiuent or by Williamson Etherification reaction.
(h) Low Methoxyrl Pectins and High Methoxyl Pectins Pectins - are the partial breakdown products of complex structures in plant cell wall (normally fruits). These can .
be modified by de-esterification to produce high methoxyl and low methoxy! pectins.
The capsules of acid may be mixed with the resin to be cured by any suitable means. The resins may be phenolic or urea formaldehyde. The very small size of the capsules facilitates dispersal in the resin. The mixing process is low energy, low shear to avoid premature rupturing of the capsules. A suitable form of mixer may be a paddle mixer. The shelf life of a product comprising resin to be cured and encapsulated acid may be tailored to a customer's requirements_ Shelf lives of at least three months and possibly of longer than one year may be achieved. -The capsules dispersed in the resin may be ruptured ~to release the acid to initiate curing by any suitable means: Appropriate means 1:. include heating, sound, ultrasound; radio waves, microwaves or pressure_ The latter may be particularly advantageous in the production of products which inherently involve the application of pressure such as for example laminated products.
Claims (24)
1. A microcapsule suitable for use in the curing of resins comprising a membrane of a water based encapsulation material and an encapsulated phase comprising one or more strong acids wherein the membrane may be ruptured by an external energy source to release the acid.
2. A microcapsule as claimed in claim 1, in which the encapsulent comprises a water based acid resistant gelatin.
3. A microcapsule as claimed in claim 1 or 2, in which the encapsulent comprises a mixture of gelatin and xanthan gum.
4. A microcapsule as claimed in claim 1 or 2, in which the encapsulent comprises a mixture of gelatin and gellan gum.
5. A microcapsule as claimed in claim 1 or 2, in which the encapsulent comprises a mixture of gum arabic and xanthan gum.
6. A microcapsule as claimed in claim 1 or 2, in which the encapsulent comprises a mixture of gelatin and tragacanth.
7. A microcapsule as claimed in claim 1 or 2, in which the encapsulent comprises a mixture of gum arabic and tragacanth
8. A microcapsule as claimed in claim 1 or 2, in which the encapsulent comprises a mixture of gelatin and gum arabic
9. A microcapsule as claimed in claim 1 or 2, in which the encapsulent comprises a mixture of gelatin and polyglycol alginates.
10. A microcapsule as claimed in claim 1 or 2, in which the encapsulent comprises a mixture of gum arabic and gellan gum.
11. A microcapsule as claimed in any of claims 3 to 10 in which the ratio of the two ingredients to each other lie in the ranges 99.9 to 49.9 and 0.1 to 50.1.
12. A microcapsule as claimed in claim 1, in which the encapsulent comprises hydrolysed gelatin, alginates; carrageenan (Kappa, Iota and Lambda), locust bean gum, gum arabic, high methoxyl pectins, gellan gum, methyl cellulose and methyl hydroxpropyl cellulose or any combination thereof or agar.
73. A microcapsule as claimed in claim 1, in which the encapsulent comprises xanthan gum combined with one of the following hydroxyethyl cellulose, carboxymethyl cellulose, gum arabic, tragacanth, gellan gum, sulphuric acid monoesters of gum tragacanth, polyglycol alginates, low methoxyl pectins.
14. A microcapsule as claimed in claim 1 or 2, in which the strong acid comprises sulphuric acid, or hydrochloric acid, or phosphoric acid, or toluene sulphonic acid or a mixture thereof.
15. A resin system for the production of rigid articles wherein said resin systems comprises resin and a dispersed catalyst/initiator said catalyst/initiator being microcapsule comprising a membrane of a water based encapsulent material and a dispersed phase comprising one or more strong acids wherein the membrane may be ruptured by an external energy source to release the acid into the resin and thereby initiating/catalysing the resin curing.
16. A fibrous carrier layer impregnated with a resin system as claimed in claim 15.
17. A fibrous carrier layer as claimed in claim 16 which is shaped while uncured.
18. A fibrous carrier layer as claimed in claim 16 or 17 which has a fibrous sheet structure including a mat, a web or randomly orientated fibres.
19. A fibrous carrier layer as claimed in claim 18, in which the fibres are of glass.
20. A method for the microencapsulation of one or more strong acids suitable for use as catalysts, promoters or initiators in resin curing reactions, comprising the following steps:
mixing the acid(s), a water based encapsulent and water, sonicating the mixture so formed to encapsulate the acid(s) in the encapsulent, and substantially removing surplus water from the mixture to form a microcapsule of the acid in the encapsulent.
mixing the acid(s), a water based encapsulent and water, sonicating the mixture so formed to encapsulate the acid(s) in the encapsulent, and substantially removing surplus water from the mixture to form a microcapsule of the acid in the encapsulent.
21. A method as claimed in claim 20 in which the mixture is sonicated with ultrasound.
22. A method as claimed in claim 21, in which the mixture is sonicated with audible sound.
23. A method as claimed in claims 20, 21 or 22, in which the capsules formed in the sonification step are heated for a period of about twenty four hours at a temperature below 80°C.
24. A method as claimed in claim 23 in which the capsules are heated at a temperature between 60° and 70°C.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9626152.4 | 1996-12-17 | ||
GBGB9626152.4A GB9626152D0 (en) | 1996-12-17 | 1996-12-17 | Encapsulation |
PCT/GB1997/003346 WO1998026865A1 (en) | 1996-12-17 | 1997-12-16 | Encapsulation |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2275377A1 true CA2275377A1 (en) | 1998-06-25 |
Family
ID=10804552
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002275377A Abandoned CA2275377A1 (en) | 1996-12-17 | 1997-12-16 | Encapsulation |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP0948397A1 (en) |
JP (1) | JP2001507051A (en) |
CN (1) | CN1248928A (en) |
AU (1) | AU727915B2 (en) |
CA (1) | CA2275377A1 (en) |
GB (1) | GB9626152D0 (en) |
NO (1) | NO992932L (en) |
WO (1) | WO1998026865A1 (en) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9909763D0 (en) * | 1998-09-12 | 1999-06-23 | Cehmcolloids Ltd | Cluring of resins |
JP2005146064A (en) * | 2003-11-13 | 2005-06-09 | Konica Minolta Medical & Graphic Inc | Dispersion of microcapsuled dye dispersion, its manufacturing process, and photosensitive material for thermal development photography |
FI20085831L (en) * | 2008-09-05 | 2010-03-06 | Graveolens Oy A | Subject composition and use thereof |
DE102009046244A1 (en) | 2009-10-30 | 2011-05-19 | Evonik Röhm Gmbh | Encapsulation of reactive components for 1-component systems using coaxial nozzles |
DE102009046251A1 (en) | 2009-10-30 | 2011-05-19 | Evonik Röhm Gmbh | Reactive 1-component road markings |
CN112079993A (en) * | 2020-09-22 | 2020-12-15 | 肇庆市海特复合材料技术研究院 | Preparation method of epoxy resin latent curing agent |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1388786A (en) * | 1972-04-03 | 1975-03-26 | Scherer Corp R P | Integral solid gel-lattice dosage form of high-moisture content |
DE3447833A1 (en) * | 1984-12-29 | 1986-07-10 | Allan Gerhard 8047 Karlsfeld Frühauf | Cloth or the like with microcapsules containing an active ingredient |
-
1996
- 1996-12-17 GB GBGB9626152.4A patent/GB9626152D0/en active Pending
-
1997
- 1997-12-16 WO PCT/GB1997/003346 patent/WO1998026865A1/en not_active Application Discontinuation
- 1997-12-16 EP EP97949004A patent/EP0948397A1/en not_active Withdrawn
- 1997-12-16 JP JP52742798A patent/JP2001507051A/en active Pending
- 1997-12-16 CA CA002275377A patent/CA2275377A1/en not_active Abandoned
- 1997-12-16 AU AU77366/98A patent/AU727915B2/en not_active Ceased
- 1997-12-16 CN CN 97181767 patent/CN1248928A/en active Pending
-
1999
- 1999-06-16 NO NO992932A patent/NO992932L/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
GB9626152D0 (en) | 1997-02-05 |
AU727915B2 (en) | 2001-01-04 |
NO992932D0 (en) | 1999-06-16 |
AU7736698A (en) | 1998-07-15 |
NO992932L (en) | 1999-08-04 |
WO1998026865A1 (en) | 1998-06-25 |
JP2001507051A (en) | 2001-05-29 |
CN1248928A (en) | 2000-03-29 |
EP0948397A1 (en) | 1999-10-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Klein et al. | Natural biopolymer‐based hydrogels for use in food and agriculture | |
Zhao et al. | Biopolymer aerogels and foams: Chemistry, properties, and applications | |
CN106620825B (en) | A kind of bi-component quick-acting haemostatic powder gel and its application | |
US3965033A (en) | Process for the production of oil-containing microcapsules | |
AU727915B2 (en) | Encapsulation | |
DE2633259C3 (en) | Method for immobilizing enzymes or enzyme-containing cells | |
JP2002121291A (en) | Water-absorbing resin powder and method for producing the same | |
CN105924596B (en) | A kind of method that fibroin base absorbent material is prepared by grafting vinyl monomers | |
WO2003084505A2 (en) | Forming a chemically cross-linked particle of a desired shape and diameter | |
CN111116973B (en) | Preparation method and application of polyvinyl alcohol hemostatic porous material with high liquid absorption and high expansion performance and active hemostatic function | |
EP2066737A1 (en) | Method for producing water absorbent resin particle | |
JPS58189031A (en) | Double micro-capsule | |
US20210363329A1 (en) | Composite particles, composite-particle composition, and method for producing composite-particle composition | |
CN105999391B (en) | A kind of preparation method of alginic acid hydrogel dressing | |
Hu et al. | Preparation and characterization of composite hydrogel beads based on sodium alginate | |
CN108607599A (en) | A kind of quantum dot-Au/C3N4Hydrogel based photocatalyst | |
CN112500544B (en) | Preparation method of chitosan/sodium alginate composite hydrogel | |
Mala et al. | Protection and controlled gastrointestinal release of bromelain by encapsulating in pectin–resistant starch based hydrogel beads | |
EP2283047B1 (en) | Filled nanoparticles | |
CN114010836B (en) | Hemostatic dressing and preparation method thereof | |
JP2001288201A (en) | Hydrolysis depolymerization of cellulose ether using acid catalyst | |
KR102124579B1 (en) | Bio-ink composition for minimizing cell necrosis and method for manufacturing a biostructure using the same | |
CN114014979A (en) | Preparation method of regenerated cellulose gel microspheres | |
CN110101871B (en) | Preparation method of embedded resveratrol | |
CN109675096A (en) | A kind of preparation method of chitin fiber aerogel dressing |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FZDE | Discontinued | ||
FZDE | Discontinued |
Effective date: 20021216 |